News for hackers. Stuff that matters.
Re:23andMe hit with class action over “misleading” genetic ads by tvladeck on Monday December 02, 2013 @08:19PM (#6837878)
To this point:

> Most of 23andme's customers were early adopters, especially when the price was much higher, I find it hard to believe the plantiffs in this lawsuit were duped into thinking it does anything more than claimed.

You've actually hit on exactly why the FDA decided to initiate enforcement action on 23andMe. The FDA has always taken the position that what 23andMe was doing was not necessarily permitted, but used regulatory discretion and did not stop them. The rationale was that since 23andMe did not do mass-marketing, the people using the tests were seeking 23andMe out and were educated on what the tests were.

23andMe has made some stupid choices, like not engaging with the FDA over the course of a number of months on this issue, and this was all brought to a head when 23andMe broke the implicit agreement with the FDA and started mass-marketing.

And on this point:

> that doesn't really promise anymore than a statistical printout of your DNA.

Their profiles now have a "key health recommendations" section if you've taken the test (I have), which, again, is a big no-no, and part of the reason that the FDA decided to initiate enforcement.

Re:23andMe hit with class action over “misleading” genetic ads by cromwellian on Monday December 02, 2013 @08:27PM (#6837909)
Lots of websites make key health recommendations based on family history/ancestry, and behavioral questionnaires. Why are they exempted?

Why can someone make a website that asks you about age, drinking, smoking, activity levels, height, weight, etc and then make health recommendations, but if it comes from sampling DNA instead of verbal questioning of potential heredity traits, it's magically different and bad?

Re:23andMe hit with class action over “misleading” genetic ads by epistasis on Monday December 02, 2013 @08:35PM (#6837938)
There's a significant amount that can go wrong in the laboratory when generating test results. So congress passed laws saying the FDA must regulate these laboratories. 23andMe chose not to comply with these regulations, to not collaborate with the FDA.

Blaming the FDA is quite misplaced. If you want the laws to be different, congress is the part of the government with power to change the regulations. The FDA seems to be attempting to do the minimal amount required by law, and does not appear to be in the least bit overzealous with 23andMe.

That 23andMe has not complied with basic QA and analytic reassurances should concern you greatly, and doubt the quality of 23andMe. What 23andMe is doing is somewhat equivalent to writing code and not having any unit tests, integration tests, or any QA team. Or perhaps they're doing all that, but don't want to report to the FDA. In any case, quite shady.

Re:23andMe hit with class action over “misleading” genetic ads by Symmetry on Monday December 02, 2013 @08:50PM (#6837993)
23andme complies with all the rules governing genetics laboratories. It's the offering the results to consumers and the interpretation that the FDA says makes it the equivalent of a medical device rather than a medical laboratory, and which puts it under a separate, much tougher regulatory regime.

EDIT: Of course Congress tells the FDA how it is to regulate genetics labs, and how it is to regulate medical devices. But I think the decision to regulate 23andme as a medical device is very much something the people in charge at the FDA had some leeway in.

Re:23andMe hit with class action over “misleading” genetic ads by timr on Monday December 02, 2013 @09:04PM (#6838039)
"23andme complies with all the rules governing genetics laboratories."

You're misunderstanding the difference between "runs a competent lab" and "provides a genetic test that's useful for diagnostics". You can run a perfectly clean, professional lab, and still offer a useless (or dangerously misleading) test.

The FDA, in this case, is more interested in the latter question than the former, and it's the most important question of all. The FDA is doing exactly what it should be doing here -- questioning the validity of the test itself, not the logistics of the lab doing the test.

Re:23andMe hit with class action over “misleading” genetic ads by cromwellian on Monday December 02, 2013 @10:18PM (#6838255)
Genetic tests are useful for many things, some people have used them for ancestry, especially African Americans who have traced history that had been obscured by slavery.

I think "test" is even the wrong terminology. A better one would be "picture" or "snapshot". A photo can be used for many purposes, one of which is to make medical diagnoses. Personally, what I want from 23andme is not a diagnosis, I just want a dump of my DNA hyperlinked with relavent scientific artifacts on suspected function or links to diseases.

The FDA can't prove that this information isn't useful, and the fact that the utility of information is unknown is not cause to ban its acquisition.

IMHO, Personal Genomics is a personal right, in the same way that consensual sex, or recreational drugs are. As I mentioned elsewhere, the FDA should prioritize going after stuff that is actually proven dangerous or fraudulent/malevolent, not preeemptively trying to cut the kneecaps off of a potentially revolutionary new cottage industry.

If they want to impose some silly advertising disclosure, fine, but I don't think the FDA should be in the business of banning this. Hopefully eventually someone makes a version which can be built by hackers, so people can shotgun analyze DNA at home and it becomes impossible to control.

Re:23andMe hit with class action over “misleading” genetic ads by timr on Tuesday December 03, 2013 @12:20AM (#6838706)
"Genetic tests are useful for many things"

Nobody is arguing that they aren't. The point is, you know nothing about the accuracy or precision of the test in question. Just because it's "genetic" doesn't mean it's a valid test.

"The FDA can't prove that this information isn't useful, and the fact that the utility of information is unknown is not cause to ban its acquisition."

That's just Not Even Wrong. The FDA's mandate isn't to prove that a drug or test isn't useful before regulating (an impossible bar) -- otherwise, we'd be back in the bad old days of patent medicines. The FDA is there to ensure that the risks of drugs and medical tests are balanced by their benefits.

Re:23andMe hit with class action over “misleading” genetic ads by cromwellian on Tuesday December 03, 2013 @12:20PM (#6841642)
In order to ensure that the risks are balanced, they need to evaluate the expected value of false negatives vs false positives. If they don't have this information, they are regulating blind.

If 23andme's gene sequencers are inaccurate, then I expect market competition between competitors over who has the most accurate sequencing. The FDA can play a role if they want to independently test sequencers and publish data like the highway safety council and crash test ratings, but I see no reason to "regulate" genetic sequencing anymore than someone should regulate mass spectrometers.

Re:23andMe hit with class action over “misleading” genetic ads by cromwellian on Tuesday December 03, 2013 @04:39PM (#6843383)
Well, excuse me for being lazy and using less specific terminology than you desire. Yes, I know how 23andme's SNP probing works. I just prefer to imagine a personal genomics market in general that evolves to the state where we can all have our full genome sequenced. And we're not going to get there without having early adopters and baby steps instead.

I don't need government protection from this, certainly not over a one time fee of $99 that has ample disclaimers, and at worst, will cause me to waste time asking my doctor over a condition I don't have, and at best, find out the cause of a disorder that doctors haven't been able to diagnose.

Yes, and in some very rare cases, some people will be told they don't have the BRCA gene when they really do, as if there's an epidemic of women have been avoiding mammograms because of DNA tests, instead of lacking healthcare, or being given confusing directives over the years over when, and how often they need to have exams.

Re:23andMe hit with class action over “misleading” genetic ads by timr on Tuesday December 03, 2013 @04:14PM (#6843236)
"If they don't have this information, they are regulating blind."

Yes, exactly. That's why they've been asking the company for that information for months, and why they shut down sales of the product until the company complies. Glad we agree that this is the right move by the FDA.

"If 23andme's gene sequencers are inaccurate, then I expect market competition between competitors over who has the most accurate sequencing."

They aren't sequencing anything -- they're using microarrays. How can you possibly have such a strong opinion on something that you know nothing about?